Answers are grounded in this paper and cite their sources.
High Resolution Image Download MS PowerPoint Slide Two new ring-size-varying analogues ( 2 and 3 ) of ipomoeassin F were synthesized and evaluated. Improved cytotoxicity (IC 50: from 1.8 nM) and in vitro protein translocation inhibition (IC 50: 35 nM) derived from ring expansion imply that the binding pocket of Sec61α (isoform 1) can accommodate further structural modifications, likely in the fatty acid portion. Streamlined preparation of the key diol intermediate 5 enabled gram-scale production, allowing us to establish that ipomoeassin F is biologically active in vivo (MTD: ∼3 mg/kg).
No takes yet. Share an insight, caveat, or question.
Zong et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: